Cargando…
MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1
Cancer stem cells are considered as the cell population which is responsible for chemoresistance and treatment failure in breast cancer patients. Therefore, it is urgent to explore the mechanism by which cancer stem cells survive under the treatment of chemotherapeutic drugs such as cisplatin. In th...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400641/ https://www.ncbi.nlm.nih.gov/pubmed/28423543 http://dx.doi.org/10.18632/oncotarget.15781 |